Zobrazeno 1 - 4
of 4
pro vyhledávání: '"59"'
Autor:
Jin Roh, Jooryung Huh, Sang-Yeob Kim, Seong Hyun Jeong, Dok Hyun Yoon, So-Woon Kim, Weon Seo Park, Cheolwon Suh, Jung Yong Hong, Joon Seong Park, Jiyeon Han, A-Neum Lee, Hye Won Lee, Chan-Sik Park, Hyo-Kyung Pak, Hyungwoo Cho, Hyeon Seok Eom
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Introduction Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma and a heterogeneous disease with a variety of molecular aberrations and diverse clinical outcomes. BCL2 expression has been implicated for a poor pr
Autor:
Carsten Weishaupt, Michael Geier, Andrea Forschner, Friedegund Meier, Ursula Dietrich, Jessica C. Hassel, Patrick Clemens, Markus Hecht, Stephan Grabbe, Ralf Gutzmer, Bülent Polat, Ricarda Rauschenberg, Carmen Loquai, Rainer Fietkau, Felix Kiecker, Lisa Zimmer, Carola Berking, Dirk Schadendorf, Simone M. Goldinger, Gerhard G. Grabenbauer, Luitpold Distel, Gerold Schuler, Jochen Utikal, Lucie Heinzerling, Panagiotis Balermpas
Publikováno v:
British Journal of Cancer
Background: Concomitant radiation with BRAF inhibitor (BRAFi) therapy may increase radiation-induced side effects but also potentially improve tumour control in melanoma patients. Methods: A total of 155 patients with BRAF-mutated melanoma from 17 Eu
Autor:
Louise E. Daly, S. Cushen, Derek G. Power, Henry Paul Redmond, Kathleen O'Sullivan, Maria Twomey, Paul Donnellan, David P Woodlock, Aoife M. Ryan, Aine O'Reilly
Publikováno v:
British Journal of Cancer
Background: Body composition is an important predictor of drug toxicity and outcome. Ipilimumab (Ipi), a monoclonal antibody used to treat metastatic melanoma, has specific toxicities. No validated biomarkers that predict Ipi toxicity and efficacy ex
Autor:
J. Shapiro, Rocío Parody, Claudio Anasetti, Mohamed A. Kharfan-Dabaja, David Valcárcel, Jose F Falantes, Guillermo Ortí, Lourdes Vázquez, Athanasios Tsalatsanis, José Luis Piñana, Albert Esquirol, Lucía López-Corral, Janelle Perkins, D Caballero, Pere Barba, Carlos Solano, Joseph Pidala, Oriana López-Godino, José A. Pérez-Simón, Rodrigo Martino
Publikováno v:
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
HLA-matched related or unrelated donors are not universally available. Consequently, patients can be offered hematopoietic stem cell transplantation (HSCT) from alternative donors, including mismatched unrelated donors (MMURD), known to cause a highe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb4a8e988ab651409982c51fb0c3f3a
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6592
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6592